Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Multidimensional Cancer Rehab Program for Patients Undergoing Allogenic Bone and Marrow Transplantation (CaRE-4-alloBMT)

NCT04966156 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT04966156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04966156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Multidimensional Cancer Rehab Program for Patients Undergoing Allogenic Bone and Marrow Transplantation (CaRE-4-alloBMT)
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
September 8, 2021
Completion date
January 31, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allogeneic disease, cancer rehabilitation, hematologic cancer